Zynaphar

ZYNAPHAR Pyrazinamide Syrup is used for the initial phase treatment of active tuberculosis in both pulmonary and extrapulmonary forms of the disease. It is a necessary component of combination therapy that aims to effectively eliminate the mycobacterium and prevent the rapid development of bacterial resistance. This antituberculosis agent acts within the acidic environment of inflammatory sites and macrophages, contributing to the overall sterilizing action of the regimen.

ZYNAPHAR Pyrazinamide Syrup is used for the initial phase treatment of active tuberculosis in both pulmonary and extrapulmonary forms of the disease. It is a necessary component of combination therapy that aims to effectively eliminate the mycobacterium and prevent the rapid development of bacterial resistance. This antituberculosis agent acts within the acidic environment of inflammatory sites and macrophages, contributing to the overall sterilizing action of the regimen.